Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg
Clinical trial NCT05160090 · COMPLETED
Trial details
- NCT number
- NCT05160090
- Sponsor
- Alembic Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-18
- Primary completion
- 2020-02-05
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.